Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
To our knowledge, this is the largest longitudinal study to date of microdosing psilocybin and one of the few studies to engage a control group. In light of these methodological strengths, the comparability of our findings with those of prior research from diverse locations and with different methodologies suggests a relatively consistent association between microdosing…
Recent Comments